Skip to main content

How can we help you?

  • Deal or case news
  • 15-12-2017

VIB is a life-sciences research institute performing basic research with a strong focus on translating scientific results into pharmaceutical, agricultural and industrial applications. Over the past few years, NautaDutilh has assisted VIB with the incorporation of several spin-offs.

The most recent project we worked on with VIB was the incorporation of Aelin Therapeutics, a privately held Belgian biotherapeutics company which has secured a EUR 27 million investment to pioneer a novel development to create a completely new class of antibiotics and first-in-class therapeutics for use against high-value undruggable human targets.

The technology, known as Pept-ins™, harnesses the power of protein aggregation to specifically induce functional knockdown of a target protein.

NautaDutilh's team, led by Elke Janssens and Florence Verhoestraete, assisted VIB.

View VIB's official press release here.

Cookie notice

We care about your privacy. We only use cookies strictly necessary to ensure the proper functioning of our website. You can find more information on cookies and on how we handle your personal data in our Privacy and Cookie Policy.